![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37525-37532, December 31, 1999
§
From the Crkl, an SH2-SH3-SH3 adapter protein, is one of
the major tyrosine phosphoproteins detected in cells from patients with
chronic myelogenous leukemia. Crkl binds to BCR/ABL through its
N-terminal SH3 domain and is known to interact with several signaling
proteins that have been implicated in integrin signaling, including
Cbl, Cas, Hef-1, and paxillin. We have previously shown that
overexpression of Crkl enhances adhesion to extracellular matrix
proteins through
Department of Adult Oncology, Dana-Farber
Cancer Institute, and the Departments of Medicine, Brigham and Women's
Hospital and Harvard Medical School, Boston, Massachusetts 02115
1 integrins. In this study, the
effects of Crkl on spontaneous and chemokine-directed migration of the
hematopoietic cell line Ba/F3 were examined. Full-length, SH2-, and
SH3(N)-domain deletion mutants of Crkl were expressed transiently as
fusion proteins with green fluorescent protein. Successfully
transfected cells were isolated by fluorescence-activated cell sorting.
The ability of these cells to migrate across a fibronectin-coated
membrane, either spontaneously or in response to the chemokine
stromal-derived factor-1
, was determined. Cells expressing green
fluorescent protein alone were not distinguishable from untransfected
or mock transfected Ba/F3 cells. However, Ba/F3 cells overexpressing
full-length Crkl were found to have an increase in spontaneous
migration of 2.8 ± 0.6-fold in seven independent assays. The
enhancement of migration required both the SH2 domain and the
N-terminal SH3 domain. Migration in response to stromal-derived
factor-1
was not significantly enhanced by overexpression of Crkl.
Overexpression of Crkii also augmented spontaneous migration but to a
lesser degree than did Crkl. Because the SH2 domain was required for enhanced migration, we looked for changes in phosphotyrosine containing proteins coprecipitating with Crkl, but not Crkl
SH2, after integrin cross-linking. Full-length Crkl, but not Crkl
SH2, coprecipitated with a single major tyrosine phosphoprotein with an
Mr of approximately 120 kDa, identified as Cbl.
The major Crkl SH3-binding protein in these cells was found to be the
guanine nucleotide exchange factor, C3G. Interestingly, overexpression
of C3G also enhanced migration, suggesting that a Cbl-Crkl-C3G complex
may be involved in migration signaling in Ba/F3 cells. These data
suggest that Crkl is involved in signaling pathways that regulate
migration, possibly through a complex with Cbl and C3G.
This article has been cited by other articles:
![]() |
P. J. S. Stork and T. J. Dillon Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions Blood, November 1, 2005; 106(9): 2952 - 2961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Rodrigues, K. E. Fathers, G. Chan, D. Zuo, F. Halwani, S. Meterissian, and M. Park CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells Mol. Cancer Res., April 1, 2005; 3(4): 183 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Valles, M. Beuvin, and B. Boyer Activation of Rac1 by Paxillin-Crk-DOCK180 Signaling Complex Is Antagonized by Rap1 in Migrating NBT-II Cells J. Biol. Chem., October 22, 2004; 279(43): 44490 - 44496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sanui, A. Inayoshi, M. Noda, E. Iwata, J. V. Stein, T. Sasazuki, and Y. Fukui DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1 Blood, October 15, 2003; 102(8): 2948 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lamorte, S. Rodrigues, V. Sangwan, C. E. Turner, and M. Park Crk Associates with a Multimolecular Paxillin/GIT2/{beta}-PIX Complex and Promotes Rac-dependent Relocalization of Paxillin to Focal Contacts Mol. Biol. Cell, July 1, 2003; 14(7): 2818 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Voss, P. Gruss, and T. Thomas The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation Development, March 2, 2003; 130(2): 355 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishihara, M. Maeda, A. Oda, M. Tsuda, H. Sawa, K. Nagashima, and S. Tanaka DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines Blood, December 1, 2002; 100(12): 3968 - 3974. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lamorte, S. Rodrigues, M. Naujokas, and M. Park Crk Synergizes with Epidermal Growth Factor for Epithelial Invasion and Morphogenesis and Is Required for the Met Morphogenic Program J. Biol. Chem., September 27, 2002; 277(40): 37904 - 37911. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. K. Goh, T. Zhu, W.-Y. Leong, and P. E. Lobie c-Cbl Is a Negative Regulator of GH-Stimulated STAT5-Mediated Transcription Endocrinology, September 1, 2002; 143(9): 3590 - 3603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. McLeod, A. H. Y. Li, R. L. Lee, A. E. Burgess, and M. R. Gold The Rap GTPases Regulate B Cell Migration Toward the Chemokine Stromal Cell-Derived Factor-1 (CXCL12): Potential Role for Rap2 in Promoting B Cell Migration J. Immunol., August 1, 2002; 169(3): 1365 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lamorte, I. Royal, M. Naujokas, and M. Park Crk Adapter Proteins Promote an Epithelial-Mesenchymal-like Transition and Are Required for HGF-mediated Cell Spreading and Breakdown of Epithelial Adherens Junctions Mol. Biol. Cell, May 1, 2002; 13(5): 1449 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Yu, T. S. Hawley, R. G. Hawley, and C.-K. Qu Role of the docking protein Gab2 in beta 1-integrin signaling pathway-mediated hematopoietic cell adhesion and migration Blood, April 1, 2002; 99(7): 2351 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuda, S. Tanaka, H. Sawa, H. Hanafusa, and K. Nagashima Signaling Adaptor Protein v-Crk Activates Rho and Regulates Cell Motility in 3Y1 Rat Fibroblast Cell Line Cell Growth Differ., March 1, 2002; 13(3): 131 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Martelli, J. Boomer, M. Bu, and B. E. Bierer T Cell Regulation of p62dok (Dok1) Association with Crk-L J. Biol. Chem., November 30, 2001; 276(49): 45654 - 45661. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kin, G. Li, M. Shibuya, and Y. Maru The Dbl Homology Domain of BCR Is Not a Simple Spacer in P210BCR-ABL of the Philadelphia Chromosome J. Biol. Chem., October 12, 2001; 276(42): 39462 - 39468. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Felschow, M. L. McVeigh, G. T. Hoehn, C. I. Civin, and M. J. Fackler The adapter protein CrkL associates with CD34 Blood, June 15, 2001; 97(12): 3768 - 3775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oda, H. D. Ochs, L. A. Lasky, S. Spencer, K. Ozaki, M. Fujihara, M. Handa, K. Ikebuchi, and H. Ikeda CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk Blood, May 1, 2001; 97(9): 2633 - 2639. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hemmeryckx, A. van Wijk, A. Reichert, V. Kaartinen, Ron de Jong, P. K. Pattengale, I. Gonzalez-Gomez, J. Groffen, and N. Heisterkamp Crkl Enhances Leukemogenesis in BCR/ABL P190 Transgenic Mice Cancer Res., February 1, 2001; 61(4): 1398 - 1405. [Abstract] [Full Text] |
||||
![]() |
R. D. Chernock, R. P. Cherla, and R. K. Ganju SHP2 and cbl participate in {alpha}-chemokine receptor CXCR4-mediated signaling pathways Blood, February 1, 2001; 97(3): 608 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. N. Deininger, J. M. Goldman, and J. V. Melo The molecular biology of chronic myeloid leukemia Blood, November 15, 2000; 96(10): 3343 - 3356. [Full Text] [PDF] |
||||
![]() |
M. Sattler, S. Verma, Y. B. Pride, R. Salgia, L. R. Rohrschneider, and J. D. Griffin SHIP1, an SH2 Domain Containing Polyinositol-5-phosphatase, Regulates Migration through Two Critical Tyrosine Residues and Forms a Novel Signaling Complex with DOK1 and CRKL J. Biol. Chem., January 19, 2001; 276(4): 2451 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pedraza-Alva, S. Sawasdikosol, Y. C. Liu, L. B. Merida, M. E. Cruz-Munoz, F. Oceguera-Yanez, S. J. Burakoff, and Y. Rosenstein Regulation of Cbl Molecular Interactions by the Co-receptor Molecule CD43 in Human T Cells J. Biol. Chem., January 5, 2001; 276(1): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dai, P. Kerzic, W. G. Schroeder, and I. K. McNiece Deletion of the Src Homology 3 Domain and C-terminal Proline-rich Sequences in Bcr-Abl Prevents Abl Interactor 2 Degradation and Spontaneous Cell Migration and Impairs Leukemogenesis J. Biol. Chem., July 27, 2001; 276(31): 28954 - 28960. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |